HODGKIN LYMPHOMA
Clinical trials for HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cheaper, easier dose of immunotherapy work just as well?
Disease control Not yet recruitingThis study tests whether giving a lower dose of the immunotherapy drug nivolumab less often can still control advanced cancers that have spread or can't be removed surgically. The goal is to make treatment more affordable and accessible worldwide. About 50 adults with various can…
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 17, 2026 01:04 UTC
-
Promising combo aims to tame hodgkin lymphoma in kids and teens
Disease control Not yet recruitingThis study tests whether adding the drug nivolumab to standard chemotherapy (AVD) can better control early-stage Hodgkin lymphoma in patients aged 2 to 21. The treatment is given to 15 participants with newly diagnosed, non-bulky disease. Researchers will monitor side effects and…
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
Engineered immune cells take on Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early-phase study tests a new treatment for people with certain blood cancers (like lymphoma) that have returned or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to target a protein called CD45 on cancer cells, along with spec…
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
Could less radiation be just as effective for hodgkin lymphoma?
Disease control Not yet recruitingThis study looks at whether people with early-stage Hodgkin lymphoma who respond well to two cycles of chemotherapy can safely receive a lower dose of radiation (20 Gy instead of the usual 30 Gy). About 518 adults will take part. The goal is to see if the lower dose works just as…
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
Engineered immune cells take on tough lymphomas in new trial
Disease control Not yet recruitingThis study tests a new treatment called CD70.CAR NK cells for people with diffuse large B-cell lymphoma or Hodgkin lymphoma that did not respond to or came back quickly after initial therapy. The therapy uses a patient's own immune cells that are modified in a lab to better find …
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
Engineered immune cells take on tough blood cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new treatment made from donor cord blood cells that are engineered to better recognize and attack certain blood cancers (like lymphoma and leukemia). The treatment is for people aged 18-75 whose cancer has returned or not responded to standard thera…
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Exercise may turn back the clock for blood cancer survivors
Knowledge-focused Not yet recruitingThis study looks at whether a special exercise program can help older adults who have survived blood cancers like leukemia or lymphoma age more slowly. Researchers want to find out how much and what type of exercise works best. About 180 people aged 50 and older will take part, a…
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Smart scans keep proton therapy on target for kids with cancer
Knowledge-focused Not yet recruitingThis study looks at whether taking extra CT or MRI scans during proton therapy for children with solid tumors or Hodgkin's lymphoma can help doctors adjust the treatment plan if the tumor or body changes shape. About 100 children will get weekly or every-other-week scans to check…
Matched conditions: HODGKIN LYMPHOMA
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC